A randomized phase 1 study investigating gut microbiome changes with moxifloxacin vs. oral vancomycin: Implications for iClostridioides difficile/i risk

Journal:

Journal of Infectious Diseases

Published:

2025-10-13

DOI:

10.1093/infdis/jiaf512

Affiliations:

4

Authors:

11

Go to article

Institutions	Authors	Share
University of Houston (UH), United States of America (USA)	7.000000	0.64
The University of Texas Health Science Center at Houston (UTHealth), United States of America (USA)	2.000000	0.18
Baylor College of Medicine (BCM), United States of America (USA)	1.000000	0.09
Texas Children's Hospital, BCM, United States of America (USA)	1.000000	0.09

Interested in Clinical Sciences?